Obesity as a risk factor for prostate cancer mortality: a systematic review and dose-response meta-analysis of 280,199 patients

M Rivera-Izquierdo, J Perez de Rojas, V Martínez-Ruiz… - Cancers, 2021 - mdpi.com
Simple Summary Results from individual studies on the association between obesity and
prostate cancer mortality remain inconclusive; additionally, several large cohort studies have …

Stem cells as target for prostate cancer therapy: opportunities and challenges

C Escudero-Lourdes, I Alvarado-Morales… - Stem cell reviews and …, 2022 - Springer
Cancer stem cells (CSCs) and cells in a cancer stem cell-like (CSCL) state have proven to
be responsible for tumor initiation, growth, and relapse in Prostate Cancer (PCa) and other …

Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registry

DJ Benjamin, A Shrestha, D Fellman… - Prostate cancer and …, 2024 - nature.com
Introduction To evaluate how often men with metastatic prostate cancer (mPC) receive
standard of care treatment with androgen deprivation therapy (ADT). Methods Men aged≥ …

The influence of age on prostate cancer screening index

J Shan, Z Liu, X Geng, Y Feng, X Yang… - Journal of Clinical …, 2022 - Wiley Online Library
Purpose This study aimed to identify parameters with a higher diagnostic value for early
screening of prostate cancer (PCa) at different ages. Materials and Methods A total of 294 …

Association between Alcohol Intake and Prostate Cancer Mortality and Survival

O D'Ecclesiis, E Pastore, S Gandini, S Caini… - Nutrients, 2023 - mdpi.com
We conducted a systematic review and meta-analysis to investigate the role of alcohol
consumption with the prognosis of prostate cancer (PCa). Published reports were gathered …

The influence of prostate volume on clinical parameters in prostate cancer screening

J Shan, X Geng, Y Lu, Z Liu, H Zhu… - Journal of Clinical …, 2022 - Wiley Online Library
Purpose The purpose of the study was to evaluate the diagnostic significance of two new
and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV) …

Spatial-temporal Bayesian accelerated failure time models for survival endpoints with applications to prostate cancer registry data

M Wang, Z Li, J Lu, L Zhang, Y Li, L Zhang - BMC Medical Research …, 2024 - Springer
Prostate cancer is the most common cancer after non-melanoma skin cancer and the
second leading cause of cancer deaths in US men. Its incidence and mortality rates vary …

Disparities in Palliative Care Use for Patients With Blood Cancer Who Died in the Hospital

TC Hsieh, YH Yeo, G Zou, C Zhou… - American Journal of …, 2024 - journals.sagepub.com
Background: Palliative care can enhance quality of life during a terminal hospitalization.
Despite advances in diagnostic and treatment tools, blood cancers lag behind solid …

Clinical research analysis based on prostate cancer screening diagnosis

J Shan, X Geng, Z Liu, Y Lu, R Zhou, Z Zhang… - Andrologia, 2022 - Wiley Online Library
This study aimed to analyse the clinical characteristics and risk factors of patients with
positive prostate biopsy at 4–20 ng/mL of prostate‐specific antigen (PSA), construct a new …

Supplementary Figure 53 Risk of bias assessment of studies included in meta-analyses................ 90 APPENDIX 2: BMI and secondary outcomes (CVD-related …

M Cariolou - Association between adiposity after diagnosis of … - bmjmedicine.bmj.com
Data items 10a List and define all outcomes for which data were sought. Specify whether all
results that were compatible with each outcome domain in each study were sought (eg for all …